Please use this identifier to cite or link to this item: https://doi.org/10.1186/s13756-016-0149-9
Title: Core components for effective infection prevention and control programmes: New WHO evidence-based recommendations
Authors: Storr, J
Twyman, A
Zingg, W
Keywords: acute health care facility
antibiotic resistance
Article
evidence based practice
good clinical practice
hand washing
health care facility
health insurance
health program
healthcare associated infection
hospital bed utilization
infection control
infection prevention
national health service
patient preference
personnel management
point of care system
practice guideline
priority journal
program effectiveness
workload
world health organization
Issue Date: 2017
Citation: Storr, J, Twyman, A, Zingg, W (2017). Core components for effective infection prevention and control programmes: New WHO evidence-based recommendations. Antimicrobial Resistance and Infection Control 6 (1) : 6. ScholarBank@NUS Repository. https://doi.org/10.1186/s13756-016-0149-9
Rights: Attribution 4.0 International
Abstract: Health care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline. © 2017 World Health Organization.
Source Title: Antimicrobial Resistance and Infection Control
URI: https://scholarbank.nus.edu.sg/handle/10635/178711
ISSN: 20472994
DOI: 10.1186/s13756-016-0149-9
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s13756-016-0149-9.pdf554.25 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons